Angiotensin I konverteringshæmmeren enalapril til behandling af progredierende kronisk nefropati: En åben randomiseret kontrolleret undersøgelse

Keyphrases

• Randomized Controlled Trial 100%
• Enalapril 100%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 100%
• Chronic Progressive Nephropathy 100%
• Blood Pressure 50%
• Glomerular Filtration Rate 50%
• Basic Treatment 50%
• No Significant Difference 25%
• Moderate to Severe 25%
• Open Study 25%
• Antihypertensive Therapy 25%
• Antihypertensive Treatment 25%
• Dialysis 25%
• Angiotensin-converting Enzyme Inhibition 25%
• Therapeutic Goals 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Chronic Kidney Failure 100%
• Enalapril 100%
• Angiotensin I 100%
• Dipeptidyl Carboxypeptidase Inhibitor 100%
• Dipeptidyl Carboxypeptidase 25%
• Antihypertensive Therapy 25%
• Antihypertensive Agent 25%
• Enzyme Inhibition 25%

Biochemistry, Genetics and Molecular Biology

• Blood Pressure 100%
• Randomized Controlled Trial 100%
• Angiotensin 100%
• Glomerulus Filtration 100%
• Enzyme Inhibitor 100%
• Angiotensin-Converting Enzyme 50%
• Enzyme Inhibition 50%